Rob Lavigne Selected Research

2,6-dichlorobenzamide

1/2021

The complete genome of 2,6-dichlorobenzamide (BAM) degrader Aminobacter sp. MSH1 suggests a polyploid chromosome, phylogenetic reassignment, and functions of plasmids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rob Lavigne Research Topics

Disease

44	Infections 01/2022 - 04/2008
8	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2012
3	Communicable Diseases (Infectious Diseases) 01/2021 - 01/2011
2	Superinfection 12/2021 - 01/2018
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2017
2	Persistent Infection 01/2021 - 07/2014
2	Cross Infection (Nosocomial Infection) 01/2021 - 01/2019
1	Wounds and Injuries (Trauma) 01/2022
1	Polyploidy 01/2021
1	Staphylococcal Skin Infections 01/2021
1	Pseudomonas Infections 01/2016
1	Muscle Cramp (Cramp) 07/2015
1	Staphylococcal Infections 05/2015
1	Burns 01/2014
1	Wound Infection (Wound Infections) 01/2014
1	Gram-Negative Bacterial Infections 01/2012

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2012
10	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2013
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
3	EnzymesIBA 01/2022 - 09/2014
3	Bacterial RNAIBA 01/2021 - 09/2014
3	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2020 - 01/2020
3	Bacterial Proteins (Bacterial Protein)IBA 04/2016 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 06/2009
2	Colistin (Coly-Mycin)FDA Link 01/2022 - 01/2019
2	Anti-Infective Agents (Microbicides)IBA 10/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2012
2	Peptides (Polypeptides)IBA 01/2017 - 07/2015
2	Peptidoglycan (Murein)IBA 02/2016 - 10/2008
1	ceftazidime drug combination avibactamIBA 01/2022
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	DNA Transposable Elements (Element, IS)IBA 01/2022
1	Neutralizing AntibodiesIBA 12/2021
1	HydrogelsIBA 12/2021
1	VaccinesIBA 01/2021
1	2,6-dichlorobenzamideIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Therapeutic UsesIBA 12/2020
1	Biological ProductsIBA 10/2020
1	Nitrate ReductaseIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Capsules (Microcapsules)IBA 01/2019
1	AntitoxinsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	degradosomeIBA 01/2017
1	Cold Shock Proteins and PeptidesIBA 04/2016
1	Adenosine Triphosphate (ATP)IBA 04/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2016
1	pyrimidineIBA 01/2016
1	O Antigens (O Antigen)IBA 10/2015
1	AlginatesIBA 10/2015
1	PyocyanineIBA 10/2015
1	UreaseIBA 10/2015
1	Vancomycin FDA LinkGeneric 07/2015
1	CathelicidinsIBA 07/2015
1	Antimicrobial PeptidesIBA 07/2015
1	SpermidineIBA 12/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2014
1	Macromolecular SubstancesIBA 10/2014
1	PowdersIBA 09/2014
1	Drinking WaterIBA 07/2014
1	Art-175IBA 07/2014
1	AcetyltransferasesIBA 03/2013
1	Amino Acids FDA Link 01/2013
1	ProteomeIBA 09/2010
1	Muramidase (Lysozyme)IBA 04/2008

Therapy/Procedure

16	Phage Therapy 01/2022 - 01/2011
5	Therapeutics 01/2022 - 01/2014
2	Salvage Therapy 01/2022 - 01/2014